The development and innovation in the sickle cell disease treatment are encouraging the growth of the sickle cell disease treatment market. For instance, stem cell transplantation is the only potential treatment to cure sickle cell disease treatment. In this treatment, the old stem cell is replaced with the healthy stem cell in bone marrow donated by a matching donor. Bone marrow is the source of new red blood cells, by the transplantation of stem cell the new flexible and round-shaped healthy red blood cells are produced in order to cure the sickle cell disease treatment.

Various medications are approved in order to treat and cure sickle cell disease treatment which is creating enormous opportunities for the sickle cell disease treatment market. For instance, in November 2019, the US FDA approved the Oxybryta (voxelotor) a therapeutic treatment for the treatment of sickle cell disease which is developed by Global Blood Therapeutics. The therapy is developed with the aim to provide prevention from the sticking of hemoglobin in order to smooth the flow of red blood cells in blood vessels to the organs maintaining the flexible shape of the red blood cell.

Request a free sample of our report on Sickle Cell Disease Treatment Market: https://www.omrglobal.com/request-sample/sickle-cell-disease-treatment-market

In November 2019, Novartis AG granted the approval of Adakveo (Crizanluzumab) by the FDA. Adakveo has an antibody that is used to block one of the proteins in the endothelial cells of the blood vessels. This antibody prevents the protein from binding the sickle cells which in turn used to reduce the pain associated with the sickle cell because of blockage in the red blood cells. The major symptom of sickle cell disease is the pain associated with sickle cell and many pain-relieving medications are prescribed in order to cure the acute pain in the patients.

A full report of Sickle Cell Disease Treatment Market is available at: https://www.omrglobal.com/industry-reports/sickle-cell-disease-treatment-market

In November 2017, Micelle Bio Pharma, Inc. granted the approval of sickle cell disease treatment Altemia and found many successful results in the reduction of vaso-occlusive crises (VOCs). Altemia is a drug containing a mixture of lipids formulated using advanced lipid technology (ALT) and is primarily designed for the treatment of sickle cell diseases.The drug has the ability to increase the fluidity of red blood cells and treatment of disease by reducing blood cell adhesion, blood cell hemolysis and inflammation.

A new CRISPER (Clustered regularly inter spaced short palindromic repeats) technology is used to replace the stem cell in order to produce a high level of fetal hemoglobin and replacing it with the damaged hemoglobin in the red blood cell. Therefore the emerging developments in the treatment options and drugs will be anticipated to boost the sickle cell disease market.

Sickle Cell Disease Treatment Market Segmentation

By Drug Type

Medication

Blood Transfusions

Bone-Marrow Transplant

By Disease

Sickle Cell Anemia

Sickle Hemoglobin C Disease

Sickle Beta Thalassemia

Sickle Beta-Zero Thalassemia

By Region

North America

The US

Canada

Europe

Germany

UK

France

Spain

Italy

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Company Profiles

Acceleron Pharma, Inc.

Arena Pharmaceuticals, Inc.

AstraZeneca plc

Baxter International, Inc.

Blue bird bio, Inc.

Bristol-Myers Squibb Co.

Eli Lilly and Co.

Emmaus Life Science, Inc.

Global Blood Therapeutics, Inc.

Medunik USA, Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/sickle-cell-disease-treatment-market

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +1 646-755-7667, +91 780-304-0404